India Glycols Limited

rs,

2025 The Manager (Listing) BSE Limited 1st Floor, New Trading Ring, Rotunda Building, P.J. Towers, Dalal Street, Bandra (East), Mumbai – 400 001 The Manager (Listing) National Stock Exchange of I

10%

Overview Figures in ₹ Cr. Gross Revenue Net Revenue EBITDA & EBITDA Margin PAT & PAT Margin +10% 2,283 2,503 7% 969 1,040 13.2% 14.5% 6.2% 7.0% +18% 128 151 +21% 60 73 Q1FY

7%

₹ Cr. Gross Revenue Net Revenue EBITDA & EBITDA Margin PAT & PAT Margin +10% 2,283 2,503 7% 969 1,040 13.2% 14.5% 6.2% 7.0% +18% 128 151 +21% 60 73 Q1FY25 Q1FY26 Q1FY25

13.2%

nue Net Revenue EBITDA & EBITDA Margin PAT & PAT Margin +10% 2,283 2,503 7% 969 1,040 13.2% 14.5% 6.2% 7.0% +18% 128 151 +21% 60 73 Q1FY25 Q1FY26 Q1FY25 Q1FY26 Q1FY25 Q1FY2

14.5%

t Revenue EBITDA & EBITDA Margin PAT & PAT Margin +10% 2,283 2,503 7% 969 1,040 13.2% 14.5% 6.2% 7.0% +18% 128 151 +21% 60 73 Q1FY25 Q1FY26 Q1FY25 Q1FY26 Q1FY25 Q1FY26 Q1FY

6.2%

ue EBITDA & EBITDA Margin PAT & PAT Margin +10% 2,283 2,503 7% 969 1,040 13.2% 14.5% 6.2% 7.0% +18% 128 151 +21% 60 73 Q1FY25 Q1FY26 Q1FY25 Q1FY26 Q1FY25 Q1FY26 Q1FY25 Q1

7.0%

ITDA & EBITDA Margin PAT & PAT Margin +10% 2,283 2,503 7% 969 1,040 13.2% 14.5% 6.2% 7.0% +18% 128 151 +21% 60 73 Q1FY25 Q1FY26 Q1FY25 Q1FY26 Q1FY25 Q1FY26 Q1FY25 Q1FY26

18%

EBITDA Margin PAT & PAT Margin +10% 2,283 2,503 7% 969 1,040 13.2% 14.5% 6.2% 7.0% +18% 128 151 +21% 60 73 Q1FY25 Q1FY26 Q1FY25 Q1FY26 Q1FY25 Q1FY26 Q1FY25 Q1FY26 ⦁ Stro

21%

& PAT Margin +10% 2,283 2,503 7% 969 1,040 13.2% 14.5% 6.2% 7.0% +18% 128 151 +21% 60 73 Q1FY25 Q1FY26 Q1FY25 Q1FY26 Q1FY25 Q1FY26 Q1FY25 Q1FY26 ⦁ Strong Performance for

128 basis point

⦁ Strong Performance for the quarter with Rev up +7%, EBITDA up 18%, PAT up 21% ⦁ EBITDA Margins up 128 basis points, PAT Margins up 80 basis points ⦁ Strong Revenue growth led by PS and BF segments, while BSPC and

80 basis point

ter with Rev up +7%, EBITDA up 18%, PAT up 21% ⦁ EBITDA Margins up 128 basis points, PAT Margins up 80 basis points ⦁ Strong Revenue growth led by PS and BF segments, while BSPC and EB were under pressure ⦁ % Margi

₹ 1,040

lights – Q1FY26 Business Performance | Q1FY26 over Q1FY25 Figures in ₹ Cr. Net Revenue stood at ₹ 1,040 Cr in Q1FY26 vs. ₹ 969 Cr in Q1FY25, up by 7.4% – Bio Fuel increased by 45.4% to ₹ 348 Cr – PS up b

“FY23 FY24 FY25 FY23 FY24 FY25 EBITDA & EBITDA Margin (%) Adj.”

“PAT Margin (%) 11.9% 319 12.9% 428 13.9% 525 5.3% 141 5.2% 173 6.1% 231 FY23 FY24 FY25 FY23 FY24 FY25 * PAT adjusted for Exceptional Income of ₹ 28.13 Cr.”

“FY23-25 CAGR 16.7% 19.2% 18.9% 28.3% 34.9% 33.1% 28.0% 28.0% FY25 9,039 3,768 15 3,783 525 13.9% 115 410 164 - 46 292 61 231 - 231 6.1% 231 6.1% 74.6 * PAT adjusted for Exceptional Income of ₹ 28.13 Cr.”

“3535 Financial Summary - Consolidated Balance Sheet Cash Flow Statement Particulars (₹ Cr.) (as at end of) FY23 FY24 FY25 Particulars (₹ Mn) FY23 FY24 FY25 Figures in ₹ Cr.”

Customised product design

1

Environment and eco-friendly

1

New range of products in pipeline

1

CIN

1

Environment and eco-friendly

Biodegradable Technical collaborations & Tie-ups US-based Scientific Design Inc. to produce high-quality bio-glycols Global tech partnership with Wittemann, Hitachi, Air Liquide and Praxair Tie-up with Bacardi for bottling of their products at the Kashipur bottling unit LanzaTech for manufacturing of specialty chemicals based on C-smart alcohol Using world-renowned ‘Sulzer Chemtech’ technology for Glycol ethers and acetates - Only manufacturer in India JV with Clariant, leader in bio-based ethoxylates and derivatives

New range of products in pipeline

i) Products derived from C-smart or Purple alcohol ii) Bio Based specialties iii) iGreen solvents including a range of bio-esters, Specialty Bio-amines etc. iv) Specialty derivatives of Poly- galactomannans v) APIs and Nutraceuticals Focusing on following major industry sectors: i) Oil & Gas Industry including refineries, ii) Automobiles iii) Metal working Industry iv) Industrial and institutional cleaning v) Rheology modifiers for Petroleum Industry vi) Food Industry vii) Health care 30 Growth Drivers High prospects of growth of industry sectors being serviced by IGL – Personal Care, Automotive, Packaging, Beverages, Oil & Gas, Home Care, Pharma, Nutraceuticals etc, Textiles – most expected to grow at near double digit or more Increasing consumer awareness and demand for sustainable products Companies taking steps to significantly decrease carbon footprint in line with USDG targets Growing demand for natural and safer products in pharma, nutraceuticals, cosmeceuticals, food ingredient

CIN

L24111UR1983PLC009097 Head office 2B, Sector-126, Noida Gautam Budh Nagar Uttar Pradesh 201304 Ankur Jain Company Secretary & Compliance Office Tel: +91-120-6860000, 3090100, 3090200 Fax: +91-120-3090111 Email: investor.relations@indiaglycols.com Ernst & Young LLP Rohit Anand rohit.anand4@in.ey.com Riddhant Kapur Riddhant.kapur@in.ey.com